Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Mar 5, 2026, 4:00 PM EST
1.267
+0.027 (2.21%)
After-hours: Mar 5, 2026, 7:48 PM EST
Revelation Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Revelation Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Revelation Biosciences.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $28,800 → $86,400 | Strong Buy | Maintains | $28,800 → $86,400 | +6,967,641.94% | Feb 14, 2023 |
| Roth Capital | Roth Capital | Strong Buy Initiates $2,419,200 | Strong Buy | Initiates | $2,419,200 | +195,096,674.19% | Feb 17, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.24
from -23.95
EPS Next Year
-3.42
from -4.24
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.75 | -2.47 | |||
| Avg | -4.24 | -3.42 | |||
| Low | -5.58 | -4.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.